A team of researchers from the Institute for Basic Science (IBS) said they identified a new pathogenesis and treatment strategy for autistic patients with epilepsy lacking the Ank2 gene.Autism spectrum disorder (ASD) is characterized by deficits in social interaction and communication, and repetitiv
As Korea and Denmark are both actively pursuing initiatives to grow their respective biotech industries, the Danish embassy in Seoul hosted a webinar on Tuesday to elaborate on the upcoming Denmark-Korea Biotech Partnership Project.The project seeks to establish connections between Danish and Korean
SK plasma said it has received approval from the Singaporean Health Sciences Authority (HSA) for its blood products -- albumin and immunoglobulin -- and began full-scale production in June.SK plasma will be the exclusive supplier of blood products totaling $30 million over the next six years, starti
A team of researchers from CHA University and CHA Hospital has discovered biomarkers that are expected to help diagnose and treat patients with recurrent miscarriages.A team of researchers led by Professor Baek Kwang-hyun from CHA University Department of Biomedical Science identified that the genes
The brawl between Samsung Biologics and Lotte Biologics, in which the former has been accusing the latter of employee poaching and trade secret infringement, has entered a new stage as Samsung recently filed a preliminary injunction against Lotte Biologics.According to industry reports, Samsung Biol
SK pharmteco said that its French cell and gene therapy (CGT) contract development and manufacturing organization (CDMO) subsidiary Yposkesi has completed its second plant, allowing the company to secure the largest CGT production capacity in Europe.According to the company, the second plant, locate
The Korean Society of Medical Oncology (KSMO) said it is preparing to organize its 16th annual meeting and 2023 International Conference (KSMO 2023) at the Grand Walker Hill Hotel in Seoul on Sept. 7-8.The conference is expected to draw a larger crowd than previous ones because the KSMO is holding c
Bioplus-Interphex (BIX) Korea 2023, a comprehensive biotechnology convention, hosted by Korea Biotechnology Industry Organization (KoreaBIO) and Reed Exhibitions Korea (RX), will bring together global experts in all areas of biotechnology from July 12 to 14 at COEX, Seoul.The first keynote session w
Korea Advanced Institute of Science & Technology (KAIST) said on Thursday that it developed a deep learning predictive model for detecting patients' risks of adverse effects to cancer immunotherapies.Cancer immunotherapy is a third-generation cancer treatment that activates a patient's immune system
Celltrion has decided on another share buyback worth 50 billion won ($38.7 million).Celltrion said Thursday it held a board meeting and decided to repurchase 314,466 shares of its common stock. It will be the company’s third share buyback, following February and March.Based on Wednesday's closing pr
Lotte Biologics said it has signed a four-way memorandum of understanding (MOU) with Lotte Holdings, Incheon Metropolitan City, and the Incheon Free Economic Zone Authority (IFEZA) to establish its biopharmaceutical production facility in Songdo.The signing ceremony, held at the IFEZ headquarters on
Global interest is mounting in advanced biopharmaceutical products. One of the reasons is the emergence of blockbuster drugs in genetic and cell therapies, led by Kymriah, a CAR-T (chimeric antigen receptor T-cell) treatment. Recently, there has been more good news concerning stem cell therapy from
Riding on the new drug-developing zeal among pharmaceutical and biotech companies, CROs (contract research organizations) are attracting attention. A case in point is Dream CIS, which has been moving briskly in recent years.Founded in 2000, Dream CIS was acquired by Hangzhou Tigermed Consulting, the
During the Covid-19 pandemic, the global spotlight naturally gravitated towards vaccine manufacturing technology. As a crucial element of epidemic prevention strategies, vaccines were perceived not merely as pharmaceutical products, but as a symbol of national sovereignty and a formidable defense me
In a bizarre turn of events, the entrance of the Ministry of Food and Drug Safety (MFDS) was adorned with large placards and hundreds of flower wreaths, all cheering on Food and Drug Safety Minister Oh Yu-kyoung.The mastermind behind this unusual sight was none other than Vision Korea, a small share
BOSTON, Mass. -- By Kim Chan-hyuk/Korea Biomedical Review correspondent -- In Korea, known as the cradle of the biosimilar industry with pioneers like Celltrion and Samsung Bioepis, there emerges another notable company making significant strides in the field of antibody-drug R&D. Prestige Biopharma
Korean pharmaceutical and biotechnology companies, including Lotte Biologics and ST Pharm, will search for opportunities to tie up with their French counterparts in the largest U.S. biotech industry fair next week.Business France, a national agency to promote the international growth of the French e
Following Pangyo, Magok, and Songdo, Gwacheon is rapidly emerging as a new biocluster candidate.Korean pharmaceutical companies have recently been gathering in one place to build a Korean-style biocluster, as they can expect synergy effects when R&D personnel and infrastructure are gathered in one p
Samsung Bioepis said that the European Commission (EC) has granted marketing authorization for Epysqli, a biosimilar referencing Soliris (ingredient: eculizumab) for the treatment of adult and children patients with paroxysmal nocturnal hemoglobinuria (PNH).Soliris is a drug developed by Alexion, a
A team of researchers at the Korea Research Institute of Bioscience and Biotechnology (KRIBB) revealed that the smaller the size of microplastics, the greater the accumulation of carcinogens in the body, which can lead to combined toxicity and cause heart deformities.Microplastics (MP) are formed th